Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance - Wikidata - wikimedia - TriplyDB

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

http://www.wikidata.org/entity/Q28269714

about

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells EMT in Breast Carcinoma-A Review Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance The Molecular Architecture of Cell Adhesion: Dynamic Remodeling Revealed by Videonanoscopy Wnt signaling in cancer stem cells and colon cancer metastasis Hijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated Neoplastic Phenotypes Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks New Insights into the Crossroads between EMT and Stemness in the Context of Cancer Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation Epithelial-Mesenchymal Transition and Breast Cancer P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion Distinctive properties of metastasis-initiating cells Recent advances in the biology of human circulating tumour cells and metastasis Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets Metastatic colonization by circulating tumour cells Genetically engineered mouse models in oncology research and cancer medicine Noncoding RNAs in Tumor Epithelial-to-Mesenchymal Transition 14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor Roles for E-cadherin cell surface regulation in cancer miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors.Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11.Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancreatic cancer cells.TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin.Transition to resistance: An unexpected role of the EMT in cancer chemoresistance.Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.Revisiting the hallmarks of cancer.Epigenetic regulation of epithelial-mesenchymal transition Inflammatory breast cancer: a model for investigating cluster-based dissemination.Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.

P2860

Q26738643-5756DE72-ABE3-416E-A9D8-ECEEFEAB761D Q26739625-4AB8295E-D6AF-451C-9481-34D14AE35DAD Q26741846-8CBC4CA5-7871-4580-8C5D-3ED844639D17 Q26742115-AE35A5EB-0F69-4A27-AC15-AF7672FE576E Q26746986-4A19E1D3-A247-443E-9BA9-17AC7099ED60 Q26747246-6807CBE1-9872-409C-B7C7-6343CBE6CCED Q26748552-12BBB6DC-A079-47A9-BA65-5C30E32A556D Q26752391-7520649B-35E5-43DD-AC1A-008E7E1B1EEA Q26752554-E1F365A1-4483-40F5-ADD0-F5758FD63B42 Q26764831-42CE2F67-5307-49DA-95C7-C4EB4519674D Q26770051-1AED7C60-8591-4958-9635-3DB0E3E7D869 Q26773055-E076650C-A1E8-4BEC-A83A-D679E7626D9E Q27308938-5ED2007C-6A36-486C-8A70-45B8CE6583DC Q27329081-BE65A7FD-C599-4A49-B2E4-A60441B74871 Q28066285-321A1D0C-7F54-4D67-81D2-DFAEE6292999 Q28069801-4D4F58CA-26E4-46BB-B7FB-55A34D3C08C3 Q28070120-7F6DBA9C-715E-4225-A0A6-3138EF6FF164 Q28076161-1B92C31A-2051-49B0-994C-E5BBE42EE6F2 Q28076164-58D48050-9359-45F7-BA13-36BE1A9D58E8 Q28079323-1C5A6D08-8DBD-417F-8D77-03C9CBB6D550 Q28080346-10FA2AE0-C002-4CE2-B0CA-B772F1BBFF76 Q28385396-92D975AB-FF14-401C-87C8-F10588D11318 Q28828478-357D020D-DCDB-433B-93F0-9F09FA0E1F5B Q30275556-4DF8ED46-4CAD-4A40-8BD1-10082DD32766 Q30359720-BFEC5C20-5252-4F7F-B316-2C47A0EB9304 Q30368024-299BE92D-406D-4F67-83DD-C1D9A197D18B Q30759342-082A35DA-2648-42C4-9828-A2A9582C5E40 Q30833421-849BACDF-BEE3-4D57-A0A2-7970585B55F4 Q33566915-245243E9-C6EC-470E-B703-FE90C55528BC Q33568354-C18A3ED4-837B-4197-9CF7-F699D6889596 Q33607505-05693B19-ED34-4BB9-A865-F7D92979E661 Q33638144-3F9A7CF8-F0FC-4ACE-B949-A1C64CB51B65 Q33649142-1793A223-9774-4227-A67F-81D909CE439E Q33650801-4EBF641A-52A4-442B-B33D-ECD896C414D1 Q33668173-7F1F98ED-CEDF-4E5D-8D8D-067B77071DB2 Q33732986-9C007052-4EAF-4536-B24C-83E2B4CEC990 Q33764436-F2B03A0F-E17B-4454-A928-2E8E3721E2CC Q33767606-2C417AE9-62CF-40E2-86E7-A1747D03EC0B Q33798322-522B8A92-28CF-4A1C-B48C-5E17DD14BFE0 Q33804175-81251CD0-B90B-44E4-B9BB-10CFA7929A26

P2860

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

http://www.wikidata.org/entity/Q28269714

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@ast

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@en

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@nl

type

label

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@ast

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@en

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@nl

prefLabel

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@ast

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@en

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@nl

P1433

Q28269714-EC2FCECE-6A35-4BC6-B1FC-8BC161666BF2

P1476

Q28269714-7D9F93F0-C441-493B-9D30-7C122815A5B3

P2093

Q28269714-009285AA-1E7A-4594-83E5-C939FEEFDE94

Q28269714-1559ED00-CD83-43AF-A7A4-8619EB445FFF

Q28269714-27CD130D-FAC4-4A2D-AF81-A0FC36A72048

Q28269714-45A6FB10-B8CB-4338-8AFB-6675CDFEE132

Q28269714-52D7289F-6A61-4133-9B0E-6B795BBCC2EC

Q28269714-7580A7A3-5725-42E4-A62C-FDD9479FAB90

Q28269714-A7F986C1-18A9-4C4F-A35A-1D47F057E957

Q28269714-B7FB86BC-0AF9-4871-AFCF-98CE021E60D4

Q28269714-B9078F82-73F9-48AE-B8DE-3CE0B4629FCC

Q28269714-CC1EFDF1-16BF-493B-9D8C-DE34788A0351

P2860

Q28269714-01BAD9E2-2B26-43CD-BD8B-63882BC8B37D

Q28269714-0D177F24-6F30-44DA-BB82-341C61D3B8AA

Q28269714-107F2023-B78E-4049-8843-D747DFC23B23

Q28269714-10B6DE36-101A-4A1B-B52E-8ADCA0DF861F

Q28269714-19878A2D-EE1E-4CF4-84C2-66E28D2257CD

Q28269714-21E32796-1A30-459C-AD5A-1E3450E9002B

Q28269714-266F2369-9E37-4095-BCEA-58CE1531B8CC

Q28269714-27BF36DB-C9EC-4BEE-9CE1-3380DBAF1501

Q28269714-3732EF84-8492-4079-9B98-47AE37F47664

Q28269714-4502BF2B-BA9D-4FBD-AB8C-0CBFB253E435

P2888

Q28269714-22F65C56-C188-4500-AB1A-8AD6E98FE669

P304

Q28269714-DE5A0FAA-F380-440A-913B-8C6A52EC142F

P31

Q28269714-B6F3EEB2-C0A2-4251-BB42-67EE62BDC987

P3181

Q28269714-D57CE7CC-7DC0-4335-AF0E-5A7B56C0062F

P356

Q28269714-F6897953-7E8D-4005-B9A0-5158E1218B66

P407

Q28269714-42197CFE-7B88-4588-B70A-E14C19C427B1

P433

Q28269714-35A38930-BE72-4AC5-A8CA-7145154D9752

P478

Q28269714-2D6EB570-2206-4D34-BDA4-A09B92EC5571

P50

Q28269714-5F607AF3-D96B-4D60-BAA9-BACA65F31A83

P577

Q28269714-638570C5-9E5A-42BC-9AE1-006269340B80

P6179

Q28269714-A10ACB15-ECFF-449E-B76E-D704C4ED1934

P698

Q28269714-314E75D2-DD35-4FAD-8CFE-D1CF17546B67

P932

Q28269714-655FCCB9-D067-4AE3-9BCB-035F29601BCF

P3181

P356

P1433

P1476

Epithelial-to-mesenchymal tran ...... contributes to chemoresistance

@en

P2093

Anna Durrans

http://www.w3.org/2001/XMLSchema#string

Dingcheng Gao

http://www.w3.org/2001/XMLSchema#string

Fuhai Li

http://www.w3.org/2001/XMLSchema#string

Hyejin Choi

http://www.w3.org/2001/XMLSchema#string

Jianting Sheng

http://www.w3.org/2001/XMLSchema#string

Juliane Troeger

http://www.w3.org/2001/XMLSchema#string

Kari R Fischer

http://www.w3.org/2001/XMLSchema#string

Linda T Vahdat

http://www.w3.org/2001/XMLSchema#string

Nasser K Altorki

http://www.w3.org/2001/XMLSchema#string

Robert F Schwabe

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

The epithelial-mesenchymal transition generates cells with properties of stem cells

The basics of epithelial-mesenchymal transition

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

Identification of selective inhibitors of cancer stem cells by high-throughput screening

Docetaxel/anthracycline combinations for breast cancer treatment

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

A global double-fluorescent Cre reporter mouse

P2888

P304

472-476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

344080

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE15748

http://www.w3.org/2001/XMLSchema#string

P407

P433

7579

http://www.w3.org/2001/XMLSchema#string

P478

527

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1045603885

http://www.w3.org/2001/XMLSchema#string

P698

26560033

http://www.w3.org/2001/XMLSchema#string

P932

4662610

http://www.w3.org/2001/XMLSchema#string